Additional Information
Market: LSE
Sector: Food Producers
EPIC: BVIC
Latest Price: 381.90p  (0.50% Ascending)
52-week High: 456.90p
52-week Low: 284.70p
Market Cap: 923.92M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !

Britvic is a United Kingdom-based manufacturer and distributor of soft drinks. The Company’s portfolio of brands includes names, such as 7UP, Ame, Britvic 55, J20, drench, Gatorade, Idris, Pennine Spring, Pepsi, Purdey’s, Red Devil, Shandy Bass, Tango and Lime Grove.

Pdf

Britvic moves on French soft drinks company Fruité in €237 million deal

18th May 2010, 8:38 am Britvic moves on French soft drinks company Fruité in €237 million deal

FTSE 250 drinks group Britvic (LSE:BVIC) is acquiring French fruit juice and syrups company Fruité for €237 million in cash, which will be partially funded through a placing of 21.7 million shares through an accelerated book build commenced this morning.


Fruité, which sells fruit juice a number of brands, including Teisseire and Moulin de Valdonne, Fruité and Pressade, is expected to be earnings enhancing in the first full year of ownership.


"With a portfolio of iconic, market-leading still brands and as France's leading independent soft drinks company, Fruité is an excellent strategic fit for Britvic. The contemplated acquisition would extend our soft drinks focus into continental Europe, would drive our already strong portfolio into new markets and would enhance our GB offering. Our successful integration of Britvic Ireland gives us the confidence that we will deliver significant cost synergies and revenue upside, and therefore deliver material incremental value for our shareholders,” Paul Moody, Chief Executive of Britvic, said.


Britvic went on to outline a number of positives it expects from the acquisition, including a stronger presence in the pure juice market, an ability to leverage both companies commercial and operating strengths and an ability to expand its presence in Western Europe, and most notably, France. 


Britvic expects the transaction to generate cost synergies in the region of €10 million by 2013.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.